FDA Inspection 746554 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3003037054

The FDA completed an inspection of Novo Nordisk A/S on September 8, 2011 in Malov. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 8, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Malov (Denmark)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
188321 CFR 211.165(a)Testing and release for distribution